| USD millions | FY2024 | FY2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.2 | 0.0 |
| Gross profit | (0.2) | 0.0 |
| Research & development | 25.1 | 66.3 |
| Selling, general & administrative | — | 21.0 |
| Selling & marketing | — | 0.0 |
| Operating expenses | 52.2 | 87.3 |
| Operating income | (52.4) | (87.3) |
| Interest expense | 0.0 | 0.0 |
| Interest income | 5.5 | 11.4 |
| Other income / expense | — | 13.2 |
| Pre-tax income | (46.9) | (74.1) |
| Income tax | 0.0 | 0.8 |
| Net income | (46.9) | (74.9) |
| Discontinued operations | — | 0.0 |
| Other net income adjustments | — | 0.0 |
| EPS, basic (per share) | (0.88) | (1.94) |
| EPS, diluted (per share) | (0.88) | (1.94) |
| EBITDA | (52.2) | (85.9) |
| Depreciation & amortization | 0.2 | 1.4 |
| Weighted average shares (shares) | 53,027,817 | 38,646,460 |
| Weighted average diluted shares (shares) | 53,027,817 | 38,646,460 |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.